BNO
Click for more information
5.26% 20.0¢ bionomics limited

Ann: BNC105 Clinical Trial In Combination With Nivolumab

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    04/01/19
    10:17
    Post #: 37021279
    • Release Date: 04/01/19 09:57
    • Summary: BNC105 Clinical Trial In Combination With Nivolumab
    • Price Sensitive: Yes
    • Download Document    Not available as of the moment.
    Likes Created with Sketch. 4  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMS High-grade Gold and Copper findings drive excitement at Red Mountain’s Flicka Lake
right-arrow Created with Sketch.
NEWS Things finally 'looking different' for up-and-down Hot Stock tip Stockland
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.